By MjInvest Editor in Chief on Wednesday, 07 December 2022
Category: Cannabis Business Executive

Utah Synthetic: Lezli Engelking and FOCUS for the Audit (Part Two)

In Part 1 of this two-part look at Utah’s ongoing struggle with synthetic cannabinoids, Christine Stenquist of TRUCE, a Utah-based patient advocacy group, outlined the roots of the situation, the…

The post Utah Synthetic: Lezli Engelking and FOCUS for the Audit (Part Two) appeared first on Cannabis Business Executive - Cannabis and Marijuana industry news.

Original link
(Originally posted by Tom Hymes)

Related Posts